Valuation — not yet established
No valuation for Convergent Bio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($1.2M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Convergent Bio
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Seed Round | $1.2M | ▮ | ▮ |
How Convergent Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Convergent Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Convergent Bio raised?
- Convergent Bio has raised $1.2M in total funding across 1 recorded rounds.
- When did Convergent Bio last raise?
- Convergent Bio last raised in Sep 2025 (Seed Round), raising $1.2M.